NO-IN-1 (Compound 7a) inhibits the production of NO with an IC50 of 3.13 µM and displays anti-inflammatory properties. It acts by downregulating the expression of COX-2 and iNOS through the inhibition of the NF-kappaB signaling pathway.
Target:
NO Synthase|||NF-kappaB|||COX
* VAT and and shipping costs not included. Errors and price changes excepted
